ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference Jan 8, 2026 07:15AM
ADC Therapeutics Announces New Employee Inducement Grant Jan 2, 2026 04:05PM
ADC Therapeutics reports 89.8% response rate in lymphoma trial Dec 3, 2025 07:30AM
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/ Dec 3, 2025 07:30AM
ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial Dec 2, 2025 04:05PM


Dec 1, 2025 04:05PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Nov 10, 2025 07:30AM ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
Nov 3, 2025 07:15AM ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
Oct 27, 2025 07:15AM ADC Therapeutics to Present at November Investor Conferences
Oct 13, 2025 07:30AM ADC Therapeutics raises $60 million in private equity financing
Oct 13, 2025 07:30AM ADC Therapeutics Announces $60 Million Private Placement
Oct 1, 2025 04:05PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Sep 2, 2025 04:05PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Aug 27, 2025 07:15AM ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
Aug 12, 2025 07:30AM ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
Aug 5, 2025 04:05PM ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025
Aug 1, 2025 04:05PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Jul 1, 2025 04:05PM ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
Jun 16, 2025 07:15AM ADC Therapeutics SA (ADCT) Announces Updated Data from ZYNLONTA Investigator-Initiated Trial R/R Marginal Zone Lymphoma
Jun 16, 2025 07:15AM ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
Jun 12, 2025 06:46AM ADC Therapeutics SA (ADCT) Prices $100M Share Offering at $3.53/sh
Jun 12, 2025 06:45AM ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
Aug 8, 2023 07:00AM ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
May 9, 2023 07:00AM ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update
May 8, 2009 10:09AM David Moenning's Daily State of the Markets: 5/8
Dec 10, 2008 09:49AM Morning Movers 12/10: Rio Tinto (RTP) Up On Capital Plans/Job Cuts; Electronic Arts (ERTS) Sinks On Guidance